Genetically Predicted Blood DNA Methylation Reveals Putative Regulatory Signals Associated with ALS Risk
PrediXcan-based MWAS of genetically predicted blood DNA methylation provides a complementary strategy for refining genetic association signals into biologically testable candidates and identifying regulatory mechanisms for further functional investigation, and adds a regulatory dimension to ALS genetic studies.